Wednesday, March 20, 2019 4:18:45 PM
The success of GW in developing pharmaceutical drugs from marijuana sent its shares from less than $9 in 2013 to more than $110 in 2016 and earned it a market value of more than $2.9 billion. And has almost doubled again.
I believe the Zynerba Pharma pipeline is comparable and as deep as GWPH. Exciting times ahead.
Armando the CEO has sold two other biotech companies for north of a billion each.
No Debt
60 Million in cash
The 21 million shares makes ZYNE shares very scarce and the possibility for a blue sky break out in the near future many catalysts.
http://ir.zynerba.com/static-files/1a4c0483-3e61-43d7-a160-ddfc45f68b64
Long
$ZYNE
&
$GWPH
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM